[1]
van Trotsenburg, P.; Stoupa, A.; Léger, J. Congenital Hypothyroidism: A 2020-2021 consensus guidelines update-An ENDO-European reference network initiative endorsed by the European society for pediatric endocrinology and the European society for endocrinology. Thyroid, 2021, 31(3), 387-419.
[2]
Coomes, M.; Devlin, T. Heme biosynthesis. In: Devlin, T.; Ed.Textbook of Biochemistry: With Clinical Correlations, 7th ed; John Wiley & Sons: Hoboken, NJ, 2011, p. 791.
[3]
Lombardi, A.; De Matteis, R.; Moreno, M. Responses of skeletal muscle lipid metabolism in rat gastrocnemius to hypothyroidism and iodothyronine administration: A putative role for FAT/CD36. Am. J. Physiol. Endocrinol. Metab., 2012, 303(10), E1222-E33.
[4]
Sayre, N.L.; Lechleiter, J.D. Fatty acid metabolism and thyroid hormones. Curr. Trends Endocrinol., 2012, 6, 65.
[5]
Manta-Vogli, P.D.; Schulpis, K.H.; Loukas, Y.L.; Dotsikas, Y. Perinatal free carnitine and short chain acylcarnitine blood concentrations in 12,000 full-term breastfed newborns in relation to their birth weight. Pediatr. Neonatol., 2020, 61(6), 620-628.
[6]
Cheng, S-Y.; Leonard, J.L.; Davis, P.J. Molecular aspects of thyroid hormone actions. Endocr. Rev., 2010, 31(2), 139-170.
[7]
Jackson-Hayes, L.; Song, S.; Lavrentyev, E.N. A thyroid hormone response unit formed between the promoter and first intron of the carnitine palmitoyltransferase-Iα gene mediates the liver-specific induction by thyroid hormone. J. Biol. Chem., 2003, 278(10), 7964-7972.
[8]
Smith, L. Updated AAP guidelines on newborn screening and therapy for congenital hypothyroidism. Am. Fam. Physician, 2007, 76(3), 439-444.
[9]
Organization, W.H. WHO Guidelines on Drawing Blood: Best Practices in Phlebotomy; World Health Organization, 2010.
[10]
Committee, A.L.Q.A. Laboratory analysis of acylcarnitines, 2020 update: A technical standard of the American College of Medical Genetics and Genomics (ACMG). Genet. Med., 2021, 23(2), 249-258.
[11]
van der Boom, T.; Gruppen, E.G.; Lefrandt, J.D.; Connelly, M.A.; Links, T.P.; Dullaart, R.P. Plasma branched chain amino acids are lower in short-term profound hypothyroidism and increase in response to thyroid hormone supplementation. Scand. J. Clin. Lab. Invest., 2020, 80(7), 562-566.
[12]
Devlin, T.M. Textbook of Biochemistry; John Wiley & Sons: Hoboken, New Jersey, 2011.
[13]
Song, J.; Shan, Z.; Mao, J.; Teng, W. Serum polyamine metabolic profile in autoimmune thyroid disease patients. Clin. Endocrinol, 2019, 90(5), 727-736.
[14]
Liu, J.; Fu, J.; Jia, Y.; Yang, N.; Li, J.; Wang, G. Serum metabolomic patterns in patients with autoimmune thyroid disease. Endocr. Pract., 2020, 26(1), 82-96.
[15]
Khan, H.; Sureda, A.; Belwal, T. Polyphenols in the treatment of autoimmune diseases. Autoimmun. Rev., 2019, 18(7), 647-657.
[16]
Baranowska-Bik, A.; Bik, W. The association of obesity with autoimmune thyroiditis and thyroid function-possible mechanisms of bilateral interaction. Int. J. Endocrinol., 2020.
[17]
Wu, S.; Tan, G.; Dong, X. Metabolic profiling provides a system understanding of hypothyroidism in rats and its application. PLoS One, 2013, 8(2), e55599.
[18]
Sjöberg, S.; Eriksson, M.; Nordin, C. L-thyroxine treatment and neurotransmitter levels in the cerebrospinal fluid of hypothyroid patients: A pilot study. Eur. J. Endocrinol., 1998, 139(5), 493-497.
[19]
Zhao, C.; Ge, J.; Jiao, R.; Li, X.; Li, Y.; Quan, H.; Yu, T.; Xu, H.; Li, J.; Guo, Q.; Wang, W. 1H-NMR based metabolomic profiling of cord blood in gestational hypothyroidism. Ann. Transl. Med., 2020, 8(6), 296.
[20]
Pucci, E.; Chiovato, L.; Pinchera, A. Thyroid and lipid metabolism. Int. J. Obes., 2000, 24(S2), S109-S112.
[21]
Maebashi, M.; Kawamura, N.; Sato, M.; Imamura, A.; Yoshinaga, K.; Suzuki, M. Urinary excretion of carnitine in patients with hyperthyroidism and hypothyroidism: Augmentation by thyroid hormone. Metabolism, 1977, 26(4), 351-356.
[22]
Sinclair, C.; Gilchrist, J.M.; Hennessey, J.V.; Kandula, M. Muscle carnitine in hypo‐and hyperthyroidism. Muscle Nerve, 2005, 32(3), 357-359.
[23]
Benvenga, S. Effects of L-carnitine on thyroid hormone metabolism and on physical exercise tolerance. Horm. Metab. Res., 2005, 37(09), 566-571.
[24]
Benvenga, S.; Ruggeri, R.M.; Russo, A.; Lapa, D.; Campenni, A.; Trimarchi, F. Usefulness of L-carnitine, a naturally occurring peripheral antagonist of thyroid hormone action, in iatrogenic hyperthyroidism: A randomized, double-blind, placebo-controlled clinical trial. J. Clin. Endocrinol. Metab., 2001, 86(8), 3579-3594.
[25]
Benvenga, S.; Lakshmanan, M.; Trimarchi, F. Carnitine is a naturally occurring inhibitor of thyroid hormone nuclear uptake. Thyroid, 2000, 10(12), 1043-1050.
[26]
Wong, S.; Hannah-Shmouni, F.; Sinclair, G.; Sirrs, S.; Dahl, M.; Mattman, A. Acylcarnitine profile in thyroid disease. Clin. Biochem., 2013, 46(1), 180-183.
[27]
Constantinou, C.; Chrysanthopoulos, P.K.; Margarity, M.; Klapa, M.I. GC− MS metabolomic analysis reveals significant alterations in cerebellar metabolic physiology in a mouse model of adult onset hypothyroidism. J. Proteome Res., 2011, 10(2), 869-879.
[29]
van Rijt, W.J.; Schielen, P.C.; Özer, Y. Instability of acylcarnitines in stored dried blood spots: The impact on retrospective analysis of biomarkers for inborn errors of metabolism. Int. J. Neonatal Screen., 2020, 6(4), 83.
